Related Experiment Videos

Macrophage colony stimulating factor promotes phagocytosis by murine microglia

Olivera M Mitrasinovic1, Valerie A M Vincent, Dilek Simsek

  • 1Neuroscience Research Laboratories, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5485, USA.

Neuroscience Letters
|June 19, 2003
PubMed

Insights

Macrophage colony stimulating factor (M-CSF) enhances microglial cell ability to clear amyloid beta (Abeta) in Alzheimer's disease research. This suggests M-CSF plays a key role in clearing toxic protein aggregates from the brain.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Macrophage colony stimulating factor (M-CSF) and its receptor are elevated in Alzheimer's disease brains.
  • M-CSF promotes microglial activation, proliferation, and pro-inflammatory cytokine release.
  • Microglia show potential for clearing amyloid beta (Abeta) in Alzheimer's disease.

Purpose of the Study:

  • To investigate the role of M-CSF in microglial phagocytosis of Abeta and other particles.
  • To determine if M-CSF influences the clearance of abnormal protein aggregates by microglia.

Main Methods:

  • Utilized cultured microglia to assess phagocytosis of fluorescent microspheres and Abeta.
  • Examined the effects of M-CSF treatment on microglial phagocytic activity.
  • Investigated the impact of antibody neutralization of M-CSF on Abeta uptake.

Main Results:

  • M-CSF treatment significantly increased microglial phagocytosis of both microspheres and Abeta.
  • Neutralizing M-CSF antibodies reduced Abeta uptake when the M-CSF receptor was overexpressed.
  • M-CSF enhances the microglial clearance capacity for Abeta.

Conclusions:

  • M-CSF plays a crucial role in enhancing microglial phagocytosis of amyloid beta.
  • Targeting M-CSF may represent a therapeutic strategy for promoting the clearance of toxic protein aggregates in Alzheimer's disease.

Related Concept Videos